190783-99-4 Usage
Description
1-Methyl-5-oxoproline methyl ester, with the molecular formula C6H9NO3, is a methyl ester derivative of 1-methyl-5-oxoproline. It is a white solid with a melting point of 81-83°C and is utilized as a reagent in organic chemistry reactions. This chemical compound serves as a building block in the synthesis of pyrrolidinone derivatives, which are of interest in medicinal chemistry due to their potential applications.
Uses
Used in Pharmaceutical Synthesis:
1-Methyl-5-oxoproline methyl ester is used as a starting material for the production of various pharmaceuticals. Its role in the synthesis process is crucial for creating a range of medicinal compounds that can address different health conditions.
Used in Pesticide Production:
In the agricultural sector, 1-Methyl-5-oxoproline methyl ester is utilized as a component in the manufacturing of pesticides. Its inclusion in these products is aimed at enhancing their effectiveness in controlling pests and protecting crops.
Used in Organic Compounds Synthesis:
1-Methyl-5-oxoproline methyl ester is also used as a building block in the synthesis of other organic compounds. Its versatility in organic chemistry allows it to be a valuable component in creating a variety of chemical products.
Used in Medicinal Chemistry:
As a precursor to pyrrolidinone derivatives, 1-Methyl-5-oxoproline methyl ester is used in medicinal chemistry for the development of potential therapeutic agents. These derivatives may possess bioactive properties that can be harnessed for treating various diseases and medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 190783-99-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,7,8 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 190783-99:
(8*1)+(7*9)+(6*0)+(5*7)+(4*8)+(3*3)+(2*9)+(1*9)=174
174 % 10 = 4
So 190783-99-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NO3/c1-8-5(7(10)11-2)3-4-6(8)9/h5H,3-4H2,1-2H3/t5-/m0/s1
190783-99-4Relevant articles and documents
BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION
-
Paragraph 0157, (2017/02/24)
The present invention relates to certain bis-heteroaryl compounds, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, Parkinson's disease with dementia, fronto- temporal dementia, Huntington's Disease, amyotrophic lateral sclerosis, and multiple system atrophy, and cancer including melanoma.
THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE
-
Page/Page column, (2013/07/31)
Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.
Novel Receptor Antagonists and Their Methods of Use
-
Page/Page column 15, (2008/06/13)
The present invention relates to novel oxo-prolinamide derivatives of formula (I) which modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration.
